Enovix Statistics
Total Valuation
Enovix has a market cap or net worth of $428.02 million. The enterprise value is $561.28 million.
| Market Cap | 428.02M |
| Enterprise Value | 561.28M |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enovix has 214.01 million shares outstanding. The number of shares has increased by 13.98% in one year.
| Current Share Class | 214.01M |
| Shares Outstanding | 214.01M |
| Shares Change (YoY) | +13.98% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 11.40% |
| Owned by Institutions (%) | 51.55% |
| Float | 189.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.91 |
| Forward PS | 10.70 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 4.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.10, with a Debt / Equity ratio of 3.15.
| Current Ratio | 9.10 |
| Quick Ratio | 8.48 |
| Debt / Equity | 3.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.41 |
Financial Efficiency
Return on equity (ROE) is -67.61% and return on invested capital (ROIC) is -13.69%.
| Return on Equity (ROE) | -67.61% |
| Return on Assets (ROA) | -12.72% |
| Return on Invested Capital (ROIC) | -13.69% |
| Return on Capital Employed (ROCE) | -24.03% |
| Weighted Average Cost of Capital (WACC) | 10.66% |
| Revenue Per Employee | $58,627 |
| Profits Per Employee | -$238,342 |
| Employee Count | 664 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | -585,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.43% in the last 52 weeks. The beta is 2.39, so Enovix's price volatility has been higher than the market average.
| Beta (5Y) | 2.39 |
| 52-Week Price Change | -77.43% |
| 50-Day Moving Average | 2.82 |
| 200-Day Moving Average | 4.93 |
| Relative Strength Index (RSI) | 35.18 |
| Average Volume (20 Days) | 10,016,542 |
Short Selling Information
The latest short interest is 57.46 million, so 26.85% of the outstanding shares have been sold short.
| Short Interest | 57.46M |
| Short Previous Month | 53.06M |
| Short % of Shares Out | 26.85% |
| Short % of Float | 30.30% |
| Short Ratio (days to cover) | 7.04 |
Income Statement
In the last 12 months, Enovix had revenue of $38.93 million and -$158.26 million in losses. Loss per share was -$0.73.
| Revenue | 38.93M |
| Gross Profit | 8.68M |
| Operating Income | -169.77M |
| Pretax Income | -158.88M |
| Net Income | -158.26M |
| EBITDA | -131.41M |
| EBIT | -169.77M |
| Loss Per Share | -$0.73 |
Balance Sheet
The company has $405.50 million in cash and $538.76 million in debt, with a net cash position of -$133.26 million or -$0.62 per share.
| Cash & Cash Equivalents | 405.50M |
| Total Debt | 538.76M |
| Net Cash | -133.26M |
| Net Cash Per Share | -$0.62 |
| Equity (Book Value) | 171.14M |
| Book Value Per Share | 0.77 |
| Working Capital | 391.26M |
Cash Flow
In the last 12 months, operating cash flow was -$111.09 million and capital expenditures -$17.72 million, giving a free cash flow of -$128.80 million.
| Operating Cash Flow | -111.09M |
| Capital Expenditures | -17.72M |
| Depreciation & Amortization | 38.37M |
| Net Borrowing | 598,000 |
| Free Cash Flow | -128.80M |
| FCF Per Share | -$0.60 |
Margins
| Gross Margin | 22.31% |
| Operating Margin | -436.12% |
| Pretax Margin | -408.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Enovix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.98% |
| Shareholder Yield | n/a |
| Earnings Yield | -36.31% |
| FCF Yield | -23.79% |
Analyst Forecast
The average price target for Enovix is $9.75, which is 387.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.75 |
| Price Target Difference | 387.50% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 92.05% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |